Efficacy of New Trio Combination for Melasma

NCT07676994 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

56

Enrollment

OTHER

Sponsor class

Conditions

Melasma

Interventions

DRUG: New trio combination
DRUG: Kligman's formula (trio)

Sponsor

Ghurki Trust and Teaching Hospital